Allergy Treatment Market - New Opportunities, Top Trends, Rising Demand, Emerging Growth, Business Development and Key Players

PORTLAND, OREGON, UNITED STATES, September 6, 2022 /EINPresswire.com/ -- Allergy Treatment Market by Type, Treatment, Dosage Form, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025, the global allergy treatment market was valued at $24,653 million in 2017 and is projected to reach $40,360 million by 2025, growing at a CAGR of 6.3% from 2018 to 2025. Based on type, the rhinitis and asthma segments accounted for more than half of the total market share in 2017.

An allergy is defined as a hypersensitive reaction to various foreign substances by the immune system. The substances that trigger an allergy are called allergens. Examples include pollens, dust mite, molds, pet dander, certain foods, and others. Patients prone to allergies are said to be allergic or atopic. The allergy treatment market is anticipated to grow at a fast pace owing to the rise in focus on new treatment developments for allergy specific drugs, advent of immunotherapy, and increase in prevalence of allergies across the globe.

Download Free Sample Copy of The Report:
https://www.alliedmarketresearch.com/request-sample/3541

North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers, surge in R&D expenditure for the development of allergy treatment, and growth in prevalence of food allergies. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in prevalence of allergic asthma owing to rise in pollution, surge in internet penetration, and rise in awareness about allergies.

Based on type, the rhinitis segment generated the highest revenue in 2017 and is expected to maintain this dominance throughout the forecast period. This is attributed to the increased prevalence of allergic rhinitis across the globe. For instance, according to the European Academy of Allergy and Clinical Immunology (EAACI), around 400 million patients suffer from rhinitis. However, the food allergy segment is expected to register highest growth rate during the forecast period.

Based on dosage form, the oral drugs segment generated the highest revenue, owing to the rise in preference among consumers toward oral drug consumption, and ease in its manufacturing process. However, intranasal dosage form is anticipated to grow at the highest CAGR throughout the forecast period.

The allergy treatment market is expected to witness a substantial growth owing to the surge in self-directed consumers and rise in awareness regarding immunotherapy treatment. Increase in traction toward incorporation of immunotherapies for the treatment of various allergies contributes to the market growth. There have been remarkable advancements in the field of immunotherapy, which have enabled key market players to focus on the development of allergen-specific immunotherapies. These factors are expected to boost the growth of the market in near future.

For Purchase Inquiry of Allergy Treatment Market Report:
https://www.alliedmarketresearch.com/purchase-enquiry/3541

Table of Content:

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 8: ALLERGY TREATMENT MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America
8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country

8.3. Europe

8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country

8.4. Asia-Pacific

8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

Major Key Players -

GlaxoSmithKline, ALK-Abelló A/S, Sallergenes Greer, Allergy Therapeutics, Sanofi SA, Johnson & Johnson, Merck Co. In, Merck KGaA, F. Hoffmann-La Roche AG, and Allergan plc.

Key Findings of the Allergy Treatment Market:

Based on type, the rhinitis and asthma segments dominated the global allergy treatment market in 2017 and are expected to maintain this trend during the forecast period.
Based on treatment, the immunotherapy segment is expected to register the highest CAGR of 8.5% from 2018 to 2025.
U.S. generated the highest revenue in the global allergy treatment market in 2017, accounting for more than half of the market in North America.
Asia-Pacific was the highest contributor in the allergy treatment market in 2017 and is anticipated to experience rapid growth during the forecast period.

For Customization Request:
https://www.alliedmarketresearch.com/request-for-customization/3541

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.